Tasca Therapeutics announced it raised $24.1 Million in an initial filing from an offering of $70.2 Million

Company

Location

About

Tasca Therapeutics is revolutionizing drug development by unlocking the potential of post-translational protein modifications. Using state-of-the-art chemical biology, computational approaches, and targeted inhibition at key metabolic nodes, Tasca tackles previously undruggable targets. Focused on hard-to-treat oncology indications, Tasca leverages its proprietary platform to develop innovative small-molecule drugs, paving the way for breakthroughs in cancer treatment.